CIP2A and cancer: New tools and technologies for genomic- or systems-level analysis, in addition to the conventional biochemistry and cell biology approaches are starting to reveal how signaling pathways of CIP2A's “oncogenic nexus” contribute to cancer development, cancer evolution, and drug resistance.